Fraud Alert: FDA Allowed Drugs with Fraudulent Testing to Remain on the Market

I’ve said it before and I’ll say it again. Essentially the entire U.S. economy is one gigantic fraud.  No one has honor anymore in this society, it is a totally forgotten and discarded virtue.  The ethos of the land is to take whatever you can however you can.  It doesn’t matter who you hurt or what sorts of immoral acts you need to do to get it.  One of the key dynamics that allows for such blatant theft is that the regulatory agencies that are supposed to protect us are in fact gatekeepers from the criminals in their respective industries.  In the financial area, this manifests with the SEC and CFTC revolving door to Wall Street.  In healthcare, it manifests with the FDA.  I’ve highlighted the FDA’s shadiness previously, most notably in my piece:  The FDA is Caught Spying on its Employees and Creating an “Enemies List.”  Now in this latest story, we find how little the FDA concerns itself with public health.  From Pro Publica:

On the morning of May 3, 2010, three agents of the Food and Drug Administration descended upon the Houston office of Cetero Research, a firm that conducted research for drug companies worldwide.

Lead agent Patrick Stone, now retired from the FDA, had visited the Houston lab many times over the previous decade for routine inspections. This time was different. His team was there to investigate a former employee’s allegation that the company had tampered with records and manipulated test data.

When Stone explained the gravity of the inquiry to Chinna Pamidi, the testing facility’s president, the Cetero executive made a brief phone call. Moments later, employees rolled in eight flatbed carts, each double-stacked with file boxes. The documents represented five years of data from some 1,400 drug trials.

Read more

Like this post?
Donate bitcoins: 35DBUbbAQHTqbDaAc5mAaN6BqwA2AxuE7G


Follow me on Twitter.